人參皂苷Rgl對(duì)大鼠心肌缺血再灌注損傷改善作用及機(jī)制探討
[Abstract]:BACKGROUND: Ischemia/repe rfusion (I/R) is the main pathological basis of repe rfusion in patients with acute coronary syndrome (ACS) after interventional or thrombolytic therapy. There is no effective drug intervention in clinic. Energy metabolism disorder is the initial link, and its induced inflammatory mediators and apoptosis play an important role in I/R injury. ATP synthase delta subunit ATP 5D is low expressed during hypoxia, resulting in insufficient ATP production in the myocardium. On the other hand, myocardial pump oxygen consumption leads to increased ATP degradation. ATP reduction is one of the main factors of myocardial contractile protein damage during ischemia. Abnormal energy metabolism and excessive production of peroxides caused by I/R destroy myocardial fibrous skeleton protein. Active oxygen radicals (ROS) can directly damage cell structure and function; on the other hand, ROS can activate nuclear factor kappa B (NF-kappa B) and activate the expression of inflammatory factors and adhesion factors through NF-kappa B, promote the interaction and outflow of leukocytes and vascular endothelial cells, aggravate vascular and vascular functions. Rho-kinase (ROCK) signaling pathway and phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) signaling pathway are important signaling pathways involved in apoptosis. The anti-apoptosis effect mediated by PI3K and its downstream molecules has become the focus of drug research. L(ginsenoside Rgl,Rg1) is one of the monomer saponins isolated from Panax ginseng and has a wide range of biological activities.A large number of studies have shown that ginsenoside has effects on cardiovascular system,nervous system and immune system,can inhibit cell apoptosis,dilate blood vessels,improve heart function,anti-aging and beauty. Objective: To evaluate the effects of ginsenoside Rg1 on myocardial ischemia-reperfusion injury in I/R rats by evaluating the effects of ginsenoside Rg1 on myocardial infarction, cardiac surface blood flow, cardiac function, myocardial energy metabolism, apoptosis, inflammation and related regulatory proteins. Methods: 144 male Spragu-Dawley (SD) rats weighing 240-260 g were randomly divided into four groups: sham group (Sham), background group (Rgl+Sham), model group (I/R). Before ischemia, Rgl (1 mg/kg, 5 mg/kg, 10 mg/kg) was continuously pumped through the left femoral vein to reperfusion for 90 minutes. Before ischemia, 30 minutes of ischemia, 30 minutes of reperfusion, 60 minutes of reperfusion and 90 minutes of reperfusion were used. Cardiac surface blood flow was measured by laser scanning Doppler flowmeter and cardiac function was measured by intracardiac catheterization. Myocardial ischemia and infarct size were stained with 2,3,5-triphenyltetrazolium chloride and Evans blue at 90 minutes after reperfusion. Fiber F-actin, stained with apoptosis, and observed the ultrastructure of myocardial fibers and mitochondria by transmission electron microscopy. RNA was extracted from myocardial tissue at 90 minutes after reperfusion and the level of ATP synthase delta subunit (ATP-5D) mRNA was detected by real-time quantitative polymerase chain reaction. The contents of adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP) and malondialde Hyde (MDA) in myocardium of rats were measured, and the contents of cardiac troponin I (cTnI) in serum of rats were detected by enzyme labeling and Western blotting. B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), cleaved caspase-3, cardiac troponin I (cTnI), Rho-kinase (Rho-kinase, ROCK) and its substrate myosin phosphatase (MYPT-1) phosphorylation, phosphorylation of phosphorylation were detected in rat myocardium. Phosphatidyl Inositol 3-kinase (PI3K) P and its phosphorylated I3K, protein kinase B (Akt) and its phosphorylated Akt, ATP-5D, phosphorylated myosin light chain (p-MLC), nuclear factor kappa B (NF-kB) in cytoplasm and nucleus were expressed in immune tissues. The expression of myeloperoxidase (MPO), intercellular adhesion molecule-1 (ICAM-1) and neutrophil adhesion molecule (CD18) in myocardial tissue was detected by chemical staining. Results: 30 minutes before ischemia, continuous intravenous infusion of Rg 1 to the end of reperfusion could reduce the infarct size of myocardium in rats. G1 can significantly reduce the myocardial morphological changes induced by I/R, including myocardial fiber breakage and mitochondrial enlargement; 2. inhibit the decrease of cTnI level in myocardium and the increase of cTnI level in serum of rats in I/R group; 3. improve the cardiac dysfunction induced by I/R; 4. inhibit the decrease of cardiac surface blood flow induced by I/R; 5. Inhibition of I/R-induced cardiomyocyte apoptosis, inhibition of Bcl-2 reduction, inhibition of Bax and Cleaved-caspase 3 increase; 6. Further increase of P-PI3K/PI3K and P-Akt/Akt ratio to play an anti-apoptotic role; 7. Inhibition of I/R-induced ROCK activation and its substrate MYPT-1 phosphorylation level; 8. Inhibition of I/R-induced cardiomyocyte plasma phosphorylation in rats Inhibition of I/R-induced elevation of ADP/ATP, AMP/ATP ratio, increase of MDA content, inhibition of I/R-induced decrease of ATP-5D mRNA and protein expression, and increase of MLC phosphorylation level. Inhibition of I/R-induced elevation of MPO, ICAM-1 and CD18 expression CONCLUSION: Rgl can ameliorate myocardial fibrous injury and myocardial apoptosis, improve myocardial structure, cardiac function and blood flow of I/R rats, and alleviate myocardial ischemia-reperfusion injury by inhibiting I/R-induced abnormalities of myocardial energy metabolism and oxidative stress. The activation of ROCK and the phosphorylation of its substrate MYPT-1, the inhibition of NF-kappa B Translocation Induced by I/R and its mediated inflammatory response, and the increase of P-PI3K/PI3K and P-Akt/Akt ratio are related.
【學(xué)位授予單位】:北京中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】:博士
【學(xué)位授予年份】:2014
【分類號(hào)】:R541.4
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳同度,張昌穎;素食大鼠的貧血現(xiàn)象[J];營(yíng)養(yǎng)學(xué)報(bào);1957年04期
2 陳偉強(qiáng);趙善廣;;自制注射用大鼠固定裝置[J];上海實(shí)驗(yàn)動(dòng)物科學(xué);1992年04期
3 肖柳英,林培英,馮昭明,張丹;不同周齡的SD大鼠生理、生化及體重的正常值測(cè)定[J];中藥新藥與臨床藥理;1996年03期
4 李淑云;簡(jiǎn)易大鼠灌胃器的制作[J];錦州醫(yī)學(xué)院學(xué)報(bào);2001年04期
5 楊明智,陳積圣;一種大鼠抓取與固定的新工具介紹[J];上海實(shí)驗(yàn)動(dòng)物科學(xué);2001年03期
6 戴英,陸群;復(fù)方H_(505)對(duì)Wistar大鼠外周血的血液流變學(xué)指標(biāo)的影響[J];中國(guó)血液流變學(xué)雜志;2001年01期
7 韋應(yīng)波,孫喜慶,曹新生,姚永杰,馮岱雅,楊長(zhǎng)斌;+Gz暴露時(shí)間對(duì)大鼠記憶功能和行為的影響[J];航天醫(yī)學(xué)與醫(yī)學(xué)工程;2003年01期
8 呂學(xué)軍,郭俊生,李敏,周利梅,張永娟;暈船大鼠體內(nèi)鐵含量的變化[J];中國(guó)職業(yè)醫(yī)學(xué);2003年04期
9 湯仁仙,王迎偉,王慧,周峰;201A中藥合劑對(duì)大鼠抗腎小球基底膜腎炎病變的影響[J];徐州醫(yī)學(xué)院學(xué)報(bào);2003年06期
10 孫同柱,付小兵,翁立新,梁雪梅,陳偉;介紹一種簡(jiǎn)易的大鼠保定方法[J];上海實(shí)驗(yàn)動(dòng)物科學(xué);2004年01期
相關(guān)會(huì)議論文 前10條
1 尹音;孫振宇;胡敏;李冬霞;;持續(xù)性高正加速度對(duì)大鼠顳頜關(guān)節(jié)損傷的作用[A];第八屆全國(guó)顳下頜關(guān)節(jié)病學(xué)及(牙合)學(xué)大會(huì)論文匯編[C];2011年
2 祝~=驤;iJ梊霞;洃克琴;崔素英;文允摪;,
本文編號(hào):2200642
本文鏈接:http://sikaile.net/yixuelunwen/mazuiyixuelunwen/2200642.html